Read expert faculty members’ summaries of state-of-the-art switch strategies in virologically suppressed patients, including switching ART in the setting of resistance, considerations for long acting injectables, and switching ART prior to or during pregnancy.
Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Paul E. Sax, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 550 KB
Released: May 6, 2022
Acknowledgements
Jointly provided by the Association of Nurses in AIDS Care and Clinical Care Options, LLC